Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 402.00
+6.00 (1.52%)
Oct 26, 2026, 3:30 PM JST
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 14.89 billion as of October 26, 2026. It is the 25,451st most valuable company in the world and the 2,185th biggest in Japan. Its market cap has increased by 34.60% in one year.
Market Cap
14.89B
Enterprise Value
11.98B
Revenue
323.00M
Global Rank
Country Rank
#2,185 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since April 22, 2021, Stella Pharma's market cap has decreased from 23.73B to 14.89B, a decrease of -37.26%. That is a compound annual growth rate of -8.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 14.89B | 115.49% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innovacell | 21.13B |
| RaQualia Pharma | 16.22B |
| CanBas | 14.07B |
| ReproCELL | 12.67B |
| AnGes | 11.57B |
| Kubota Pharmaceutical Holdings | 9.57B |
| Immuno-Biological Laboratories | 9.34B |
| StemRIM | 9.28B |